Research published in the medical journal JAMA estimates that close to half of all new brand-name prescription drugs launched in the United States in 2020 and 2021 came with an original price tag of at least $150,000 a year, a finding that sparked fresh calls for Congress to rein in the pharmaceutical industry’s virtually unchecked power to drive up costs.
Ugandan Health Ministry Says No Child Will Be Vaccinated Against Covid Without Parental Consent